摘要
他汀类药物是3-羟基-3-甲基戊二酰辅酶A(HMGCoA)还原酶的抑制剂,是目前最经典和有效的调脂药物,已广泛应用于心脑血管疾病的预防和治疗。新近研究表明,他汀类药物除具有抗动脉粥样硬化作用外,还具有抗炎症反应、抗氧化损伤、免疫调节甚至抑制病原微生物的作用。
出处
《中华医学杂志》
CAS
CSCD
北大核心
2012年第34期2446-2448,共3页
National Medical Journal of China
参考文献25
-
1Chopra V, Flanders SA. Does statin use improve pneumonia outcomes?. Chest, 2009, 136 : 1381-1388.
-
2Chalmers JD, Singanayagam A, Murray MP, et al. Prior statin use is associated with improved outcomes in community-acquired pneumonia. Am J Med, 2008, 121:1002-1007.
-
3Lee TM, Lin MS, Chang NC. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin. Am J Cardiol, 2008, 101 : 530-535.
-
4Grosser N, Erdmann K, Hemmerle A, et al. Rosuvastatin npregulates the antioxidant defense protein heine oxygenase-1. Biochem Biophys Res Commun, 2004, 325:871-876.
-
5Nath N, Gift S, Prasad R, et al. Potential targets of 3-hydroxy-3- methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy. J Immunol, 2004, 172 : 1273-1286.
-
6Jerwood S, Cohen J. Unexpected antimicrobial effect of statins. J Antimicrob Chemother, 2008, 61:362-364.
-
7Ou XM, Wen FQ, Uhal BD, et al. Simvastatin attenuates experimental small airway remodelling in rats. Respirology, 2009, 14:734-745.
-
8Chen YJ, Chen P, Wang HX, et al. Simvastatin attenuates acrolein-induced mucin production in rats: involvement of the Ras/extracellular signal-regulated kinase pathway. Int Immunopharmacol, 2010, 10:685-693.
-
9夏书月,康健,姜彦多,黄德生,王实,庞宝森.辛伐他汀对烟雾暴露大鼠肺泡上皮细胞的作用[J].中华结核和呼吸杂志,2010,33(11):806-810. 被引量:6
-
10Alexeeff SE, Litonjua AA, Sparrow D, et al. Statin use reduces decline in lung function : VA Noimative Aging Study. Am J Respir Crit Care Med, 2007, 176:742-747.
二级参考文献41
-
1夏熙郑,巨春蓉.Smads蛋白和转化生长因子β_1在大鼠慢性阻塞性肺疾病中的表达[J].中国呼吸与危重监护杂志,2006,5(3):193-197. 被引量:4
-
2Bellisarii FL, Gallina S, De Caterina R. Tumor nercosis factor- alpha and cardiovascular diseases. Ital Heart J, 2001, 2: 408- 417.
-
3Nishimura T, Vsazar LT, Faul JL, et al. Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells. Circulation, 2003, 108 : 1640- 1645.
-
4Nishimura T, Faul JL, Berry GJ, et al. Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats. Am J Respir Crit Care Med, 2002, 166:1403-1408.
-
5] Murata T, Sato K, Hori M, et al. Decreased endothelial nitricoxide synthase(eNOS) activity resulting from abnormal interaction between eNOS and its regulatory proteins in hypoxia-induced pulmonary hypertension. J Biol Chem, 2002, 277: 44085-44092.
-
6Murata T, Kinoshita K, Hori M, et al. Statin protects endothelial nitric oxide synthase activity in hypoxia-induced pulmonary hypertension. Arterioscler Thromb Vase Biol, 2005, 25 : 2335- 2342.
-
7Girgis RE, Li D, Zhan X, et al. Attenuation of chronic hypoxic pulmonary hypertension by simvastatin. Am J Physiol Heart Circ Physiol, 2003, 285 : H938-945.
-
8Tuder RM, Groves B, Badesch DB, et al. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol, 1994, 144:275- 285.
-
9Dorfmtiller P, Perros F, Balabaniam K, et al. Inflammation in pulmonary arterial hypertension. Eur Respir J, 2003, 22 : 358- 363.
-
10Kinlay S. Potential vascular benefits of statins. Am J Med, 2005, 118(Suppl 12A) : 62-67.
共引文献12
-
1卢献灵,何建国.他汀类药物治疗肺动脉高压的作用及机制[J].中华心血管病杂志,2010,38(10):954-957. 被引量:4
-
2吴兵凤,客占东.辛伐他汀对慢性阻塞性肺疾病疗效观察[J].黑龙江医药,2011,24(5):786-787.
-
3王晓芳,陆慰萱,郭军,李国,张运剑.罗格列酮对野百合碱诱导肺动脉高压大鼠肺血管病变的影响[J].中华医学杂志,2012,92(30):2144-2147.
-
4张春曦,黄达德,陈敏东.间充质干细胞联合辛伐他汀对动力性肺动脉高压的影响[J].广州医药,2012,43(6):1-3. 被引量:3
-
5关为群,陈雅瑜.辛伐他汀对人正常牙髓细胞和脂多糖诱导的人牙髓细胞增殖的影响[J].中国医院药学杂志,2013,33(7):522-526. 被引量:1
-
6祝国风,黄敏,凌春华.他汀类药物治疗肺高压:我们找对方向了吗[J].中华结核和呼吸杂志,2013,36(4):304-306. 被引量:1
-
7陈丹丹,周达新.他汀类药物在肺动脉高压动物模型中的机制研究进展[J].中国临床药学杂志,2013,22(3):192-196. 被引量:2
-
8王生浩,刘双,杨京华,王增智,李杰,侯微微.贝前列素联合辛伐他汀对野百合碱诱导的肺动脉高压大鼠的保护作用[J].中华医学杂志,2013,93(22):1691-1695. 被引量:2
-
9鄢高亮,胡圣大,王庆捷,王栋,王婧,乔勇,汤成春,马根山,顾雨春.地高辛早期干预对低氧诱导肺动脉高压大鼠肺血管重构的影响及其机制[J].中华医学杂志,2014,94(2):139-143. 被引量:5
-
10刘茜,王喜春,甘丹,张劼.辛伐他汀对老年COPD合并PAH患者VEGF水平及肺功能的影响[J].重庆医学,2015,44(6):761-762. 被引量:14
同被引文献52
-
1刘平,张运,王苏加,张风河,郑培惠.冠状动脉粥样硬化性心脏病与牙周病的相关性[J].中国医学科学院学报,2006,28(2):169-172. 被引量:10
-
2孙芳,陈美云.急性肺损伤/急性呼吸窘迫综合征药物治疗进展[J].国际呼吸杂志,2006,26(11):813-816. 被引量:7
-
3MeunnanJH, Sanz M,Janket S]. Oral health, atherosclerosis, and cardiovascular disease. Crit Rev Oralbiol Med,2004 ,15 :403413.
-
4DeS tefano F, Anda RF, Kahn HS, et al. Dental disease and risk of coronary heart disease and mortality. BMJ, 1993, 306: 688- 69l.
-
5Ross R. Atherosclerosis -an inflammatory disease. N EnglJ Med, 1999, 340: ll5-126.
-
6Lopes- Virella MF, Virella G. Immunological and microbiological factors in the pathogenesis of atherosclerosis. Clin Immunol Immunopathol, 1985, 37: 377-386.
-
7Spahr A, Klein E, Khuseyinova N, et al. Periodontal infections and coronary heart disease: role of periodontal bacteria and import ance of total pathogen burden in the coronary event and periodontal disease (COR-ODONT)study. Arch Intern Med,2006, 166: 554-559.
-
8Arbes SJ, Slade GD, BeckJD. Association between extene of periodontal attachment loss and self-reported history of heart attack: an analysis of NHANES ill dataJ Dent Res, 1999, 78: 1777.
-
9WilliamsJK, Sukhova GK, Herrington DM, et al. Pravastatin has cholesterol-lowering independent effects on the artery wall of atheroscleretic monkeys.JAm Coll Cardiol, 1998, 31 :684-691.
-
10MuhlesteinJB, AndersonJL, CarlquistJF, et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. Circulation, 2000, 102: 1755-1760.
二级引证文献21
-
1孙广普,杜佳,陈三俊,张继伟,王广.脑动脉支架内再狭窄的危险因素研究进展[J].世界最新医学信息文摘,2021(17):59-60.
-
2钟红.替硝唑局部用药治疗牙周炎的临床疗效及安全性分析[J].医学信息(医学与计算机应用),2014,0(26):639-640. 被引量:3
-
3元小平,李立峰.替硝唑治疗加重型口腔感染的近期效果及安全性分析[J].中国生化药物杂志,2014,34(2):97-98. 被引量:7
-
4周平,罗云,邢娜,卢珊,孙桂波,孙晓波.肿瘤坏死因子α介导动脉粥样硬化发生机制的研究进展[J].世界中医药,2015,10(8):1163-1168. 被引量:24
-
5孟宪花.局部应用替硝唑治疗牙周炎的疗效及安全性分析[J].全科口腔医学电子杂志,2015,2(10):114-114. 被引量:8
-
6陈玲园,黄天国,韩辉.阿托伐他汀对老年轻度高血压合并动脉粥样硬化患者的疗效及患者动态血压分析[J].检验医学与临床,2017,14(1):89-92. 被引量:9
-
7李珊珊,郭雨声,王芳,赵月光,旦菊花,唐文如.他汀类药物治疗牙周炎的研究进展[J].中华口腔医学杂志,2017,52(2):91-95. 被引量:4
-
8王淑珍,李博.血清炎症因子的变化与老年颅内动脉狭窄支架成形术后再狭窄的相关性[J].中国老年学杂志,2017,37(12):2927-2928. 被引量:7
-
9陈志宏.早期肺表面活性物质联合呼吸机治疗早产儿呼吸窘迫综合征的临床疗效[J].中国妇幼保健,2017,32(20):5008-5010. 被引量:10
-
10王璐,许凤.慢性牙周炎患者应用种植修复的长期疗效分析[J].全科口腔医学电子杂志,2016,3(12):22-23. 被引量:1
-
1王江.他汀类药物的临床研究进展[J].临床医学,2010,30(1):110-111. 被引量:3
-
2陈康.他汀类药物防治相关疾病研究现状[J].武警后勤学院学报(医学版),2012,21(10):836-840. 被引量:10
-
3葛长江,曹岩菁,胡申江.他汀类药物非调脂作用机制的研究进展[J].国外医学(老年医学分册),2002,23(5):214-218. 被引量:3
-
4张继业.他汀类药物的非降脂作用[J].心脏杂志,2001,13(1):52-53. 被引量:2
-
5吴士尧,胡靖超.他汀类药物非降脂作用的再认识[J].国外医学(心血管疾病分册),2003,30(1):5-7. 被引量:32
-
6章义利,吴波拉.褐藻多糖硫酸酯的药理学研究进展[J].海峡药学,2008,20(10):14-17. 被引量:2
-
7傅得兴,谢荣瑞.降胆固醇新药——HMGCoA还原酶抑制剂[J].中国药学杂志,1992,27(2):111-113.
-
8祝家庆.他汀类调脂药物研究的最新进展[J].世界核心医学期刊文摘(眼科学分册),2002,0(1):64-65. 被引量:6
-
9高艳虹,王一尘.他汀类药物与骨质疏松症研究进展[J].中国综合临床,2005,21(2):191-192.
-
10覃军,李爱民,何作云.他汀类药物对血管平滑肌细胞的直接作用及其意义[J].中国动脉硬化杂志,2000,8(4):373-375. 被引量:17